Wang Ningli

[Expert Profile] Wang Ningli, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in ophthalmology in China, working at Beijing Tongren Hospital, Capital Medical University. He has long been dedicated to clinical diagnosis, treatment, and scientific research of glaucoma, pathological myopia, and difficult complex ophthalmological diseases, and is an important leading figure in ophthalmology both domestically and internationally.

[Education & Career] Professor Wang Ningli graduated from a renowned medical university, completed systematic clinical training in the Department of Ophthalmology at Beijing Tongren Hospital, and further studied at famous international ophthalmology centers. He has long served as Director of the Eye Center at Beijing Tongren Hospital, holding important academic positions including Chair of the Ophthalmology Branch of the Chinese Medical Association. He has presided over major projects including the National Key R&D Program, and is an academic leader in the field of ophthalmology in China.

[Areas of Expertise] Professor Wang specializes in early diagnosis and precision treatment of glaucoma, comprehensive management of pathological myopia and related complications, as well as diagnosis and treatment of difficult complex ophthalmological diseases. He has profound expertise in minimally invasive glaucoma surgery (MIGS), drainage valve implantation, evidence-based treatment decision-making, and optic nerve protection research. He excels at managing difficult glaucoma patients with "difficult-to-control intraocular pressure and progressive visual field defects," helping numerous patients preserve vision and avoid blindness.

[Academic Achievements & Industry Contributions] Professor Wang has led the establishment of a Chinese glaucoma epidemiology and clinical research system, systematically mapping out the current status of glaucoma prevalence and diagnosis and treatment in China, and promoting the implementation of national actions for early glaucoma screening and treatment. He has led multiple international multi-center studies on glaucoma surgery and drug treatment, with findings published in top international ophthalmology journals, and has led the development of Chinese glaucoma diagnosis and treatment guidelines. He has actively promoted blindness prevention and treatment and popularization of appropriate ophthalmological techniques, organized cataract sight restoration and glaucoma prevention public welfare initiatives, and made outstanding contributions to the development of ophthalmology and eye health in China.

[Clinical Practice & Outstanding Contributions] For decades on the front lines of ophthalmology clinical work, Professor Wang has treated tens of thousands of patients with glaucoma and various difficult ophthalmological conditions, with exceptional surgical skill and significant treatment outcomes. Leading his team, he has successfully managed numerous difficult glaucoma patients on the verge of blindness. He has received multiple national awards including the National Science and Technology Progress Award, and has been repeatedly invited to deliver keynote reports at international ophthalmology conferences. He is a truly deserving leading figure in the field of ophthalmology in China, deeply admired by patients and peers alike.

[Honors & Reputation] Professor Wang Ningli serves as Director of the Eye Center at Beijing Tongren Hospital and Chair of the Ophthalmology Branch of the Chinese Medical Association, among other academic positions. He has presided over national-level projects including the National Key R&D Program, and is an authoritative expert in the field of ophthalmology in China. He has led the establishment of a Chinese glaucoma epidemiology and clinical research system, promoted national actions for early glaucoma screening and treatment, led multiple international multi-center studies on glaucoma surgery and drug treatment, with findings published in top international ophthalmology journals and receiving the National Science and Technology Progress Award. He has actively promoted blindness prevention and eye health initiatives, organized cataract sight restoration and glaucoma prevention public welfare activities, and trained a large number of ophthalmology leaders. He is deeply trusted by patients and respected by peers alike.